Please use this identifier to cite or link to this item:
|Title:||t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)|
|Authors:||Russell, Lisa J.|
Karran, E. Loraine
Moorman, Anthony V.
Strefford, Jonathan C.
Dyer, Martin J. S.
Harrison, Christine J.
|Publisher:||American Society of Hematology|
|Citation:||Blood, 2008, 111 (1), pp. 387-391.|
|Abstract:||Translocations involving the immunoglobulin heavy chain locus (IGH@) at chromosome band 14q32 are common in mature B-cell neoplasms, but are rare in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report the translocation, t(6;14)(p22;q32), involving IGH@ as a novel recurrent translocation in 13 BCP-ALL patients. Fluorescence in situ hybridization and long-distance inverse polymerase chain reaction identified ID4 as the partner gene. Breakpoints were scattered over a 19kb region centromeric of ID4. Quantitative real-time PCR showed upregulation of ID4 mRNA. All patients had deletions of CDKN2A and PAX5 located on the short arm of chromosome 9, frequently as a result of an isochromosome, i(9)(q10) (9/13, 69%). This study defines a new subgroup of BCP-ALL characterized by ID4 over-expression and CDKN2A and PAX5 deletions. Preliminary survival data suggest that this subgroup may be associated with a good response to therapy.|
|Rights:||This is the author's final draft of the paper published as Blood, 2008, 111 (1), pp. 387-391. Copyright © 2008 American Society of Hematology. This material is posted here with permission of the American Society of Hematology. The final version can be obtained from http://bloodjournal.hematologylibrary.org/cgi/content/abstract/111/1/387. Doi: 10.1182/blood-2007-07-092015|
|Appears in Collections:||Published Articles, MRC Toxicology Unit|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.